UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Zega Financial LLC

Zega Financial LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the second quarter, Holdings Channel.com reports. The fund owned 7,868 shares of the healthcare conglomerate’s stock after selling 23 shares during the period. UnitedHealth Group makes up approximately 0.7% of Zega Financial LLC’s investment portfolio, making the stock its 16th biggest position. Zega Financial LLC’s holdings in UnitedHealth Group were worth $4,007,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. O Brien Greene & Co. Inc lifted its position in shares of UnitedHealth Group by 76.3% during the second quarter. O Brien Greene & Co. Inc now owns 730 shares of the healthcare conglomerate’s stock worth $372,000 after purchasing an additional 316 shares in the last quarter. Vanguard Personalized Indexing Management LLC boosted its position in UnitedHealth Group by 4.5% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 83,839 shares of the healthcare conglomerate’s stock valued at $42,554,000 after buying an additional 3,589 shares during the period. Tredje AP fonden increased its position in shares of UnitedHealth Group by 17.0% during the second quarter. Tredje AP fonden now owns 381,905 shares of the healthcare conglomerate’s stock worth $194,489,000 after acquiring an additional 55,500 shares during the period. Argent Trust Co boosted its holdings in UnitedHealth Group by 2.4% in the second quarter. Argent Trust Co now owns 33,683 shares of the healthcare conglomerate’s stock valued at $17,153,000 after purchasing an additional 785 shares during the period. Finally, Meiji Yasuda Life Insurance Co raised its position in UnitedHealth Group by 28.8% in the 2nd quarter. Meiji Yasuda Life Insurance Co now owns 50,527 shares of the healthcare conglomerate’s stock valued at $25,731,000 after purchasing an additional 11,313 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.9 %

Shares of UNH stock opened at $577.89 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The business’s 50 day moving average is $572.79 and its two-hundred day moving average is $519.00. The company has a market capitalization of $531.88 billion, a P/E ratio of 35.32, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. UnitedHealth Group’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.14 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Morgan Stanley raised their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Monday. Barclays increased their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Finally, Truist Financial upped their price target on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Insiders Place Their Bets

In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.